NCT03560440View on ClinicalTrials.gov

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

CompletedOBSERVATIONAL
Enrollment

368

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2017

Conditions
Gram-Positive Bacterial Infections
Interventions
OTHER

Plasma exposure vancomycin

Investigation of plasma exposure of vancomycin.

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03560440 - Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients | Biotech Hunter | Biotech Hunter